Jefferies keeps GBp 4,000 target for Croda stock

Published on 10/15/2026 at 21:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Croda's Q3 sales update is scheduled for November 5, 2026, with a virtual event. Croda stock costs EUR 42.83 on October 15, 2026 at 9:19 p.m. CEST.

Target and upcoming events

Jefferies reaffirmed its buy rating on September 25, 2026.
Croda's virtual Q3 sales update is scheduled for November 5, 2026.
Croda stock costs EUR 42.83 at Lang & Schwarz on October 15, 2026 at 9:19 p.m. CEST.
Croda's price-to-earnings ratio was 63.45 on October 15, 2026.

Pop-Art-Comic mit lachendem Chemiker und bunt sprudelnden Reagenzgläsern im Labor — Croda International Plc (ISIN GB00BJFFLV09) wird augenzwinkernd als Pop-Art-Comic mit Chemiker und bunten Reagenzgläsern gezeigt, Illustration mit AI erstellt.

Jefferies Financial Group reaffirmed a buy rating on Croda and kept a GBp 4,000 price target in its report dated September 25, 2026, according to MarketBeat. Against the LSE price of GBp 3,589.00, that target is 11.45 percent higher. Croda stock was trading at EUR 42.83 at Lang & Schwarz on October 15, 2026 at 9:19 p.m. CEST.

Q3 date comes into view

Croda's financial calendar lists a virtual Q3 sales update for November 5, 2026. The date is published on the company's investor calendar, which also lists a UBS European Conference on November 10, 2026 and an investor site visit on November 16, 2026. The next sales update is the nearest scheduled corporate event for the stock.

Croda develops specialty chemical ingredients for consumer care, agriculture and pharma markets. The company describes its products as ingredients used at low inclusion levels but designed to influence the performance of customers' products, according to Croda.

Stock sits near yearly high

The LSE quote stood at GBp 3,589.00 on October 15, 2026 at 4:57 p.m. BST. Its 52-week range was GBp 2,488.00 to GBp 3,594.00, leaving the price 0.14 percent below the high. Trading volume was 530,213 shares against an average of 477,948.

Valuation and market size

Croda's market capitalization was GBP 5.0 billion on October 15, 2026, while its price-to-earnings ratio was 63.45. The trailing dividend yield was 0.03 percent. The valuation sits above Evonik's price-to-earnings ratio of 82.44 only when the two companies' differing earnings bases are considered, so the ratio alone does not establish a ranking.

Comparison with peers

Croda: P/E 63.45, market capitalization GBP 5.0 billion
Evonik (Xetra, EUR): P/E 82.44, market capitalization EUR 9.9 billion
DSM (Euronext Amsterdam, EUR): P/E 41.62, market capitalization EUR 763.7 million

Price remains the anchor

The scheduled November date and the Jefferies target give investors two clearly dated reference points, while the market value places Croda close to its 52-week high. The LSE quotation and the euro indication represent separate venues and currencies.

The further course of trading is shown by the continuously updated real-time quote of Croda stock.